Exact FDA event identifier

Event 88910

1 recalled-product record grouped only because every row carries this exact official event ID.

Event summary

Timeline bucket: November 08, 2021
Product types: Drug
Classifications: Class II
Statuses: Terminated
Recalling firm wording: TOLMAR, Inc.

Dossier provenance

Source snapshots represented here

openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Device root-cause evidence is not applicable to this event. No grouped product has the official product type device; this is not an unavailable-enrichment finding.

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Clindamycin and Benzoyl Peroxide Gel, 1%/5% 25 g jars, Rx only, Mfg by TOLMAR Inc. Fort collins, CO 80526, NDC 0781-7263-68

D-0282-2022

Recall number: D-0282-2022
Initiated: November 08, 2021
Classification: Class II
Status: Terminated
Recalling firm: TOLMAR, Inc.
Quantity: Unavailable

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0

Superpotent

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Superpotent Drug

Code information

Lot #: 11557C1, Exp. Date: Feb 2022; 11552B1, Exp. Date Apr 2022; 12206A1, Exp. Date: Nov 2022

Distribution pattern

Nationwide within the United States